Sorrento Announces Completion of Enrollment in the Cynviloq™ Registrational TRIBECA™ Study
January 28, 2015 at 09:02 AM EST
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, ...